Savara Inc. (Nasdaq: SVRA), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced ...

Baffles incorporated into the interior design of the nebulizer produce smaller particles and force large particles to reenter the solution ... nose versus mouth inhalation, airway obstruction ...

of solution to fill the nebulizer. The mortality rate in this study, with a cohort of 83% ICU patients, was 18% (12 patients). Eighty-three percent of those from whom repeat specimens were ...

As of 12:46 PM EDT. Market Open. Loading Chart for SVRA ...

Feasibility is about whether you can effectively implement your solution. Technically, anything is feasible, depending upon how much time you have. Adding a new feature or building a new app shouldn’t ...

After hours: October 17 at 6:33 PM EDT Loading Chart for UTHR ...